Hernia repair is one of the most common surgical procedures performed and more than 1 million hernia procedures are conducted every year in India. At a time when patients have become more aware of their health status because of the COVID-19 pandemic, Dr Vipin Jain, Senior General and Laparoscopic Surgeon at C.K. Birla Hospital, Jaipur, launched ‘Choose to Conform’ campaign to emphasize on the importance of timely Inguinal Hernia treatment using Anatomical 3-dimensional Mesh.
‘Choose to Conform’ campaign will raise patient awareness on the importance of advanced solutions available for Hernia repair that offer reduced post-operative pain, shorter recovery period and minimal scar formation.
Elaborating on the timely treatment for Hernia, Dr Vipin Jain says, “Hernia is asymptomatic and doesn’t cause any discomfort to patients. This often leads to delayed procedures that may result in serious complications later. A cancelled or delayed elective surgery may have unintended consequences that could inflict significant harm due to morbidity and mortality.”
He added, “Elective surgeries are not optional surgeries but non-urgent surgeries. However, through ‘Choose to Conform’ campaign, we want to encourage patients to get their timely treatment using advanced solutions. We continue to review the preoperative preparations for elective surgical procedures during the pandemic and offer revolutionized Hernia treatment for our patients. Minimally invasive surgical routes using the new and advanced Anatomical 3-dimensional Mesh to repair Hernia instead of the traditional surgical method is known to have improved patient outcomes.”
Pavan Mocherla, Managing Director-BD-India/South Asia said, “Awareness is the first step towards seeking the right course of treatment for better patient outcomes. In India, hernia is an increasingly common yet deeply ignored health condition that requires better patient awareness. We are pleased to introduce BD’s Choose to Conform campaign to inform patients of the latest solutions that are now available to treat hernia. With such initiatives, BD will continue advancing what’s possible in hernia treatment today and for the future.”